Pharmacist Struck Off After Large-Scale Unsafe Online Supply of Controlled Drugs Worldwide
Date of Decision: March 16, 2026
Registrant's Role: Pharmacist
Allegations:
- Operating an online dispensing service linked to Healthinfoservices Limited without adequate governance, safeguards, risk assessments, SOPs, or audit systems
- Failure to verify prescriptions, patient identity, and clinical appropriateness
- Supplying medicines internationally, including to the USA, without appropriate licences or indemnity insurance
- Dispensing approximately 39,000 prescription items, including high-risk medicines such as: Opioids (e.g., codeine, dihydrocodeine); Benzodiazepines (e.g., diazepam, clonazepam, lorazepam); Z-drugs (zopiclone, zolpidem); Gabapentin and modafinil.
- Excessive and repeated supplies of controlled drugs to individual patients
- Supplying large quantities of addictive medicines without safeguards against misuse
- Exporting controlled drugs without a Home Office licence
- Falsifying customs declarations by labelling medicines as “health supplements”
- Failing to maintain proper controlled drug registers and safe storage
- Not disclosing a directorship in Healthinfoservices Limited to a GPhC inspector
- Acting dishonestly and without integrity, including prioritising financial gain over patient safety
Outcome: Removal from the register
GPhC Standards Breached:
- Standard 1 – Provide person-centred care
- Standard 5 – Use professional judgement
- Standard 6 – Behave in a professional manner (honesty and integrity)
- Standard 8 – Speak up when concerns arise
- Standard 9 – Demonstrate leadership and manage risks appropriately
Case Summary
Allegations
This case concerns a highly serious and large-scale failure of professional standards involving the registrant, who operated an international online dispensing service linked to Healthinfoservices Limited.
The pharmacy dispensed approximately 39,000 items over four years, many of which were high-risk controlled drugs, including opioid analgesics (codeine, dihydrocodeine), benzodiazepines (e.g., diazepam, clonazepam, lorazepam), and Z-drugs such as zopiclone and zolpidem. These medicines carry well-known risks of dependency, misuse, and overdose, particularly when supplied without proper clinical oversight.
Continue Reading the Full Case
This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.